State IN
Clinical Trials in Indiana
Indiana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Indiana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 185 actively recruiting studies with Indiana sites out of 185 registered in total. The busiest research areas in Indiana are Heart Failure, Atopic Dermatitis, Stroke. Leading sponsors running trials in the state include Indiana University, National Cancer Institute (NCI), Novartis Pharmaceuticals. By stage, Indiana trials break down as Phase 1 (16), Phase 2 (43), Phase 3 (63), Phase 4 (4).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Indiana
Heart Failure (4)Atopic Dermatitis (3)Stroke (3)Multiple Myeloma (3)Heart Diseases (3)Cardiovascular Diseases (3)Gastroparesis (3)Malignant Solid Neoplasm (2)Atrial Fibrillation (2)Non-muscle Invasive Bladder Cancer With Carcinoma in Situ (2)Metastatic Gastric Adenocarcinoma (2)Colorectal Cancer (2)
Frequently Asked Questions — Clinical Trials in Indiana
How many clinical trials are currently recruiting in Indiana?
ClinicalMetric currently tracks 185 actively recruiting clinical trials with at least one location in Indiana. The total number of registered studies—including active but not currently enrolling trials—is 185. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Indiana?
Indiana hosts clinical trials across a broad range of medical conditions, including Heart Failure, Atopic Dermatitis, Stroke, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Indiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Indiana?
To join a clinical trial in Indiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Indiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Indiana
NCT06999733 Phase 1, Phase 2
Recruiting
A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic...
Condition
Neurotrophic Keratitis
Enrollment
60 pts
Location
United States
Sponsor
Krystal Biotech, Inc.
NCT07136012 Phase 3
Recruiting
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a)...
Condition
Cardiovascular Disease
Enrollment
11,000 pts
Location
United States, Australia, Canada
Sponsor
Amgen
NCT06632444 Phase 3
Recruiting
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease...
Condition
Metabolic Dysfunction Associated Steatohepatitis (MASH)
Enrollment
1,800 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT05812807 Phase 3
Recruiting
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who H...
Condition
Anatomic Stage II Breast Cancer AJCC v8
Enrollment
1,295 pts
Location
United States, Canada, Puerto Rico
Sponsor
Alliance for Clinical Trials i
NCT07128095 N/A
Recruiting
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
Condition
COVID-19
Enrollment
100 pts
Location
United States
Sponsor
Indiana University
NCT06388421 N/A
Recruiting
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension As...
Condition
Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Enrollment
900 pts
Location
United States, Puerto Rico
Sponsor
United Therapeutics
NCT07415044 Phase 2
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Condition
Ulcerative Colitis (UC)
Enrollment
1,431 pts
Location
United States, Argentina, Brazil
Sponsor
Eli Lilly and Company
NCT06873945 Phase 3
Recruiting
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alop...
Condition
Alopecia Areata
Enrollment
1,330 pts
Location
United States, Canada, China
Sponsor
Pfizer
NCT04700657 N/A
Recruiting
The Prevalence of Hypoesthesia Related Keratitis in Ocular Graft Vs. Host Diseas...
Condition
Ocular GVHD
Enrollment
30 pts
Location
United States
Sponsor
Indiana University
NCT06430801 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Partici...
Condition
Crohn's Disease
Enrollment
1,200 pts
Location
United States, Australia, Austria
Sponsor
Merck Sharp & Dohme LLC
NCT05112601 Phase 2
Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System...
Condition
Endometrial Adenocarcinoma
Enrollment
81 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07648264 Phase 3
Recruiting
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to ...
Condition
Secondary Immune Deficiency
Enrollment
63 pts
Location
United States, Belgium, Canada
Sponsor
CSL Behring
NCT04088071 N/A
Recruiting
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Condition
Paroxysmal Atrial Fibrillation
Enrollment
20,000 pts
Location
United States, Canada
Sponsor
Heart Rhythm Clinical and Rese
NCT03180268 Phase 3
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade...
Condition
Grade 2 Meningioma
Enrollment
163 pts
Location
United States, Canada, India
Sponsor
NRG Oncology
NCT06664697 N/A
Recruiting
Post-Market Clinical Investigation of the IotaSOFT Insertion System
Condition
Hearing Loss, Cochlear
Enrollment
50 pts
Location
United States
Sponsor
iotaMotion, Inc.
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Age...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
1,314 pts
Location
United States, Australia, Brazil
Sponsor
Merck Sharp & Dohme LLC
NCT07284784 Phase 2, Phase 3
Recruiting
A Study of Buntanetap in Participants With PD
Condition
Parkinson's Disease (PD)
Enrollment
500 pts
Location
United States
Sponsor
Annovis Bio Inc.
NCT07766655 Phase 3
Recruiting
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
Condition
Smoking Cessation
Enrollment
705 pts
Location
United States
Sponsor
Axsome Therapeutics, Inc.
NCT07155174 Phase 2
Recruiting
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activ...
Condition
Small Cell Lung Cancer
Enrollment
180 pts
Location
United States, Belgium, China
Sponsor
AbbVie
NCT07457918 Phase 3
Recruiting
Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients Wi...
Condition
Common Warts (Verruca Vulgaris)
Enrollment
600 pts
Location
United States
Sponsor
Verrica Pharmaceuticals Inc.
NCT04871542 N/A
Recruiting
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Condition
Malignant Solid Neoplasm
Enrollment
2,062 pts
Location
United States, Chile, Guam
Sponsor
SWOG Cancer Research Network
NCT05822141 N/A
Recruiting
Omega-3 Fatty Acids as Regulators of Brown Adipose Tissue During Cold Exposure
Condition
Cold Exposure
Enrollment
30 pts
Location
United States
Sponsor
Indiana University
NCT06124157 Phase 2
Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatme...
Condition
B Acute Lymphoblastic Leukemia
Enrollment
222 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT05500807 Phase 1
Recruiting
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Condition
Von Willebrand Disease, Type 3
Enrollment
40 pts
Location
United States
Sponsor
Bleeding and Clotting Disorder
NCT05945329 N/A
Recruiting
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Brea...
Condition
Capsular Contracture Associated With Breast Implant
Enrollment
250 pts
Location
United States
Sponsor
C. R. Bard
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology